Therapeutic drug monitoring (TDM) and model‐informed precision dosing (MIPD) have
evolved as important tools to inform rational dosing of antibiotics in individual patients with …

Background Owing to its low risk of adverse effects, teicoplanin has been extensively used
in patients with infections caused by MRSA. To promote the better management of patients …

We read with great interest the editorial by Baron et al. suggesting the potential use of
teicoplanin as an alternative drug to treat patients infected with severe acute respiratory …

Purpose: Early initiation of antibiotics is essential for ameliorating infections in critically ill
patients. The correct dosage of antibiotics is imperative to ensure their adequate exposure …

Teicoplanin has a potential antiviral activity expressed against severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2) and was suggested as a complementary option to …

Background A trough concentration (C min)≥ 20 μg/mL of teicoplanin is recommended for
the treatment of serious methicillin-resistant Staphylococcus aureus (MRSA) infections …

Due to the high bacterial resistance to antibiotics (AB), it has become necessary to adjust the
dose aimed at personalized medicine by means of therapeutic drug monitoring (TDM). TDM …

Introduction Patients in intensive care units (ICU) are often developing severe infections in
which are associated with significant mortality rates. A number of novel technologies for the …

We read with interest the paper by Giacobbe et al. estimating a cumulative risk of developing
at least one bloodstream infection (BSI) episode (largely due to Gram-positive pathogens) of …

Abstract What Is Known and Objective There are few reports on the distribution of the
plasma trough concentration (C min) of teicoplanin in patients with augmented renal …